Vitt Daniel 4/A
4/A · IMMUNIC, INC. · Filed Jun 20, 2025
Insider Transaction Report
Form 4/AAmended
IMMUNIC, INC.IMUX
Vitt Daniel
DirectorCEO and Director
Transactions
- Award
Stock Option
2025-06-05+1,558,000→ 1,558,000 totalExercise: $0.77Exp: 2035-06-05→ Common Stock (1,558,000 underlying) - Purchase
Common Stock
2025-06-04$0.77/sh+15,000$11,550→ 29,000 total
Holdings
- 362,877(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).
- [F2]362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.
- [F3]25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.